| Sep 19 |
IMAC Holdings Inc. Launches Subsidiary Ignite Proteomics and Announces Groundbreaking Precision Oncology Case Study Utilizing RPPA Technology
|
| Aug 23 |
IMAC Holdings receives notification of deficiency from Nasdaq
|
| Aug 23 |
IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q
|
| Jul 11 |
IMAC Holdings, Inc. Appoints Dr. Matthew Schwartz and Dr. Peter Beitsch to Board of Directors
|
| Jun 25 |
DayDayCook Names Jeffrey Ervin as Co-Chief Financial Officer
|
| Jun 13 |
IMAC Holdings files to sell common stock and warrants, size not disclosed
|
| May 24 |
IMAC Holdings appoints Faith Zaslavsky as CEO
|
| May 24 |
IMAC Holdings Announces Leadership Succession
|
| May 7 |
IMAC Holdings Acquires Assets of Theralink to Continue Precision Medicine Business
|
